pH-triggered small molecule nanodrugs self-assembled from tryptamine-cinnamaldehyde and fisetin for targeted sepsis-associated encephalopathy therapy
Journal of Biomaterials Applications · 2025
DOI: 10.1177/08853282251318052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomaterials Applications, 2025. Verfasst von Ximing Deng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, The Second Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Tryptamines, Brain Diseases, Acrolein, Sepsis. Die Arbeit nennt 30 Literaturangaben. Gefördert von: the Open Fund of Anhui Province Key Laboratory of Clinical and Preclinical Research in Respiratory Disease, the Key Scientific Research Projects of Department of Education of Anhui Province of China, the Natural Science Foundation of Anhui Province.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis-associated encephalopathy (SAE) is an acute diffuse brain dysfunction, but its clinical treatment just focuses on antibiotics and supportive therapy, which fail to directly limit the development of SAE. Herein, this work highlights the development of pH-triggered small molecule nanodrugs self-assembled from tryptamine (Try)-cinnamaldehyde (CA) and fisetin for targeted SAE therapy. The imine linkage in Try-CA and acid-dependent protonation of Try and fisetin endow the nanodrugs with pH-triggered dynamic changes of particle sizes, surficial charges, and drug release. Moreover, the combined use of Try-CA and fisetin also endows the nanodrugs with superior antioxidative, anti-inflammatory and antibacterial capabilities compared to their individual use. These characteristics of the nanodrugs facilitate long-term circulation stability, effective penetration through BBB, selective accumulation in the brain, and target to central and peripheral focal areas, thereby achieving comprehensive treatment or relief of SAE. Thus, these attractive experimental results illuminate the enormous potential of such pH-triggered small molecule nanodrugs for targeted SAE therapy, advancing their use in clinics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, The Second Hospital of Anhui Medical University, Hefei, China.
- Department of Critical Care Medicine, First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
- School of Pharmacy, Anhui University of Chinese Medicine, Hefei, China.
- Engineering Research Center for Biomedical Materials, Anhui Key Laboratory of Modern Biomanufacturing, School of Life Sciences, Anhui University, Hefei, China.
ORCID-Profile: Jinyao Zhou, Wei Fang, Guoqing Yan
Förderung
- the Open Fund of Anhui Province Key Laboratory of Clinical and Preclinical Research in Respiratory Disease
- the Key Scientific Research Projects of Department of Education of Anhui Province of China
- the Natural Science Foundation of Anhui Province
Zitieren
APA
Deng, X., Zhou, J., Fang, W., Sun, R., Yan, G., & Sun, Y. (2025). pH-triggered small molecule nanodrugs self-assembled from tryptamine-cinnamaldehyde and fisetin for targeted sepsis-associated encephalopathy therapy. Journal of Biomaterials Applications. https://doi.org/10.1177/08853282251318052
Vancouver
Deng X, Zhou J, Fang W, Sun R, Yan G, Sun Y. pH-triggered small molecule nanodrugs self-assembled from tryptamine-cinnamaldehyde and fisetin for targeted sepsis-associated encephalopathy therapy. Journal of Biomaterials Applications. 2025. doi:10.1177/08853282251318052
BibTeX
@article{Deng2025,
author = {Deng, Ximing and Zhou, Jinyao and Fang, Wei and Sun, Rao and Yan, Guoqing and Sun, Yun},
title = {pH-triggered small molecule nanodrugs self-assembled from tryptamine-cinnamaldehyde and fisetin for targeted sepsis-associated encephalopathy therapy},
journal = {Journal of Biomaterials Applications},
year = {2025},
doi = {10.1177/08853282251318052}
}
EUVIMED